News

Recent Medicare changes include the apparent disappearance of consultation codes, the addition of site-specific soft-tissue excision codes, and increasing pressure from overseers and auditors, says an expert.

One dermatologists describes her success with radiofreqency microneedling to treat acne and acne scarring.

Insurers tend to think of keloids as a cosmetic issue so they have a wide range of standards covering reimbursement for care and treatments. Practitioners must fully document the medical necessity of the care they provide and then code the conditions and treatments correctly to maximize their chance for reimbursement.

Fresh after her presentations on fat reduction and cellulite treatment devices at ASDS, Sue Ellen Cox, M.D., offers unplugged advice about today’s technologies.

Cellfina is subscision of the fibrous attachments between the skin and fat layers. It is the only FDA-cleared device to have solid three-year data showing that the cellulite doesn’t come back, expert says.

Immune checkpoint inhibitors are providing rapid and durable responses for patients with metastatic Merkel cell carcinoma.

Newer tools to help diagnose challenging lesions include combined immunohistochemical stains and a growing array of genetic tests, one of which has shown the potential to gauge metastatic risk.

A U.S. dermatologist shares his experience working with a Chinese plastic surgeon who does a high-volume of scar treatments.

Research in dermatology comprises only a small portion of the total amount of money spent yearly on research in fields such as internal medicine, neurology and cancer. The need for interested and talented individuals to tackle the big challenges in dermatology is greater than ever before, and practitioners are looking at ways to make the most of limitations in funding, compensation and opportunities that stand in the way of recruiting more qualified individuals to the research ranks.

Laser treatments, non-steroid injectables, and topical applications of imiquimod cream are proving to be effective in the treatment of keloids and excessive scarring. In many cases, recurrence rates have dropped to 20% and lower from former highs of 70% or more.

The FDA announced it has approved Eucrisa (Anacor Pharmaceuticals, crisaborole) ointment to treat mild to moderate eczema in patients two-years-of-age and older.

Research aimed at understanding the host-microbial interface in atopic dermatitis is ongoing but already providing insights for novel therapeutic strategies.

This month, we take a look at when to use biologics, advances in pediatric Atopic Dermatitis (AD), and how Trump’s presidency might impact dermatology.

Visual assessment of a burn injury is insufficient to judge the depth of a burn; hypertrophic scars left by burn injuries are increasingly being treated with lasers with impressive results.

Newer topical agents for rosacea including ivermectin and brimonidine are effective, and soon could be joined by oxymetazoline cream, experts say. Initial results from phase 2 trials of minocycline foam in rosacea could be available by year's end.

For decades, a lack of scientific data and evidence-based medicine have resulted in essentially no changes in the treatment of keloid disorder. New studies confirm that cryotherapy and intralesional injections of vincristine can be effective treatments for different types of keloids.

Hand moisturization is difficult to accomplish because the hands are washed more frequently than any other body part, thus experiencing both chemical and physical trauma.

"While there is little that can be done from a medical perspective to improve the ridges, cosmetic improvement is possible," says Zoe Diana Draelos, M.D.

Senile purpura on the hands and arms is a common problem seen in elderly patients.

Melanoma’s burden is increasing and the rising rates cannot simply be attributed to increased disease detection, according to a research letter published last month in JAMA Dermatology.

You might be surprised about what researchers have uncovered about why teens tan. Having a better understanding of their motives, could help you help them.

Keeping abreast of findings regarding the immunological, neurological and vascular roots of rosacea helps dermatologists target treatments accordingly, experts say.

Many dermatologists are approached by parties interested in acquiring a practice. Knowing ahead of time what questions you should ask-and how to answer their questions-can turn a simple inquiry by them into a wealth of information for you.

Dermatology’s leaders share perspectives on how the new Administration may impact medicine.

In 2016, Dermatology Times provided several articles offering guidance on the business side of dermatology. Spanning such topics as using social media effectively, to designing the ideal office space and whether or not a cash-based model is right for you, these were the top five practice management articles of 2016.

Several dermatologists go over what they're most excited about to see in 2017 in a number of different topics ranging from AD treatment to off-label technology use, to more male patients.

The National Psoriasis Foundation has recently published psoriasis treatment goals, which will help physicians and patients discuss treatment options and set expectations for outcomes.

In 2016, Dermatology Times, in partnership with VisualDx, quizzed you on a number of different skin disease diagnoses. From morphea to poikiloderma of civatte to livedo reticularis, we’ve shown cases that have stumped the most experienced dermatologists.Here are the three most-puzzling quizzes of 2016.

In this month's Clinical Considerations, we take a look at AD and bullying, whether or not derms are doing enough for psoriasis patients, and the potential of Epicutaneous immunotherapy.

Energy-based treatments can be used on their own or in conjunction with medical treatments to address chronic dermatological conditions like melasma, acne, and vitiligo.